According to WHO, breast cancer incidence is increasing so that the search for novel chemotherapeutic options is nowadays an essential requirement to fight neoplasm subtypes. By exploring new effective metal-based chemotherapeutic strategies, many ruthenium complexes have been recently proposed as antitumour drugs, showing ability to impact on diverse cellular targets. In the framework of different molecular pathways leading to cell death in human models of breast cancer, here we demonstrate autophagy involvement behind the antiproliferative action of a ruthenium(III)-complex incorporated into a cationic nanosystem (HoThyRu/DOTAP), proved to be hitherto one of the most effective within the suite of nucleolipidic formulations we have developed for the in vivo transport of anticancer ruthenium(III)-based drugs. Indeed, evidences are implicating autophagy in both cancer development and therapy, and anticancer interventions endowed with the ability to trigger this biological response are currently considered attractive oncotherapeutic approaches. Moreover, crosstalk between apoptosis and autophagy, regulated by finely tuned metallo-chemotherapeutics, may provide novel opportunities for future improvement of cancer treatment. Following this line, our in vitro and in vivo preclinical investigations suggest that an original strategy based on suitable formulations of ruthenium(III)-complexes, inducing sustained cell death, could open new opportunities for breast cancer treatment, including the highly aggressive triple-negative subtype.

Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer / Piccolo, Marialuisa; Misso, Gabriella; Ferraro, MARIA GRAZIA; Riccardi, Claudia; Capuozzo, Antonella; Zarone, Mayra Rachele; Maione, Francesco; Trifuoggi, Marco; Stiuso, Paola; D'Errico, Gerardino; Caraglia, Michele; Paduano, Luigi; Montesarchio, Daniela; Irace, Carlo; Santamaria, Rita. - In: SCIENTIFIC REPORTS. - ISSN 2045-2322. - 9:1(2019), pp. 7006-7020. [10.1038/s41598-019-43411-3]

Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer

Piccolo, Marialuisa
Primo
;
Misso, Gabriella;FERRARO, MARIA GRAZIA;Riccardi, Claudia;Capuozzo, Antonella;Maione, Francesco;Trifuoggi, Marco;D'Errico, Gerardino;Paduano, Luigi
;
Montesarchio, Daniela
;
Irace, Carlo
Co-ultimo
;
Santamaria, Rita
Co-ultimo
2019

Abstract

According to WHO, breast cancer incidence is increasing so that the search for novel chemotherapeutic options is nowadays an essential requirement to fight neoplasm subtypes. By exploring new effective metal-based chemotherapeutic strategies, many ruthenium complexes have been recently proposed as antitumour drugs, showing ability to impact on diverse cellular targets. In the framework of different molecular pathways leading to cell death in human models of breast cancer, here we demonstrate autophagy involvement behind the antiproliferative action of a ruthenium(III)-complex incorporated into a cationic nanosystem (HoThyRu/DOTAP), proved to be hitherto one of the most effective within the suite of nucleolipidic formulations we have developed for the in vivo transport of anticancer ruthenium(III)-based drugs. Indeed, evidences are implicating autophagy in both cancer development and therapy, and anticancer interventions endowed with the ability to trigger this biological response are currently considered attractive oncotherapeutic approaches. Moreover, crosstalk between apoptosis and autophagy, regulated by finely tuned metallo-chemotherapeutics, may provide novel opportunities for future improvement of cancer treatment. Following this line, our in vitro and in vivo preclinical investigations suggest that an original strategy based on suitable formulations of ruthenium(III)-complexes, inducing sustained cell death, could open new opportunities for breast cancer treatment, including the highly aggressive triple-negative subtype.
2019
Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer / Piccolo, Marialuisa; Misso, Gabriella; Ferraro, MARIA GRAZIA; Riccardi, Claudia; Capuozzo, Antonella; Zarone, Mayra Rachele; Maione, Francesco; Trifuoggi, Marco; Stiuso, Paola; D'Errico, Gerardino; Caraglia, Michele; Paduano, Luigi; Montesarchio, Daniela; Irace, Carlo; Santamaria, Rita. - In: SCIENTIFIC REPORTS. - ISSN 2045-2322. - 9:1(2019), pp. 7006-7020. [10.1038/s41598-019-43411-3]
File in questo prodotto:
File Dimensione Formato  
41598_2019_Article_43411.pdf

accesso aperto

Descrizione: articolo principale
Tipologia: Versione Editoriale (PDF)
Licenza: Dominio pubblico
Dimensione 2.81 MB
Formato Adobe PDF
2.81 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/753348
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 47
  • ???jsp.display-item.citation.isi??? 45
social impact